Marshall Wace North America L.P. purchased a new position in Wright Medical Group N.V. (NASDAQ:WMGI) during the second quarter, according to its most recent 13F filing with the SEC. The firm purchased 384,213 shares of the medical device company’s stock, valued at approximately $10,374,000. Marshall Wace North America L.P. owned approximately 0.37% of Wright Medical Group N.V. at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Mcrae Capital Management Inc. increased its position in shares of Wright Medical Group N.V. by 2.7% in the first quarter. Mcrae Capital Management Inc. now owns 9,457 shares of the medical device company’s stock worth $294,000 after buying an additional 250 shares in the last quarter. Teacher Retirement System of Texas increased its position in shares of Wright Medical Group N.V. by 6.8% in the second quarter. Teacher Retirement System of Texas now owns 7,884 shares of the medical device company’s stock worth $217,000 after buying an additional 502 shares in the last quarter. Legal & General Group Plc increased its position in shares of Wright Medical Group N.V. by 1.7% in the second quarter. Legal & General Group Plc now owns 36,752 shares of the medical device company’s stock worth $1,009,000 after buying an additional 597 shares in the last quarter. First Mercantile Trust Co. increased its position in shares of Wright Medical Group N.V. by 21.7% in the second quarter. First Mercantile Trust Co. now owns 4,380 shares of the medical device company’s stock worth $120,000 after buying an additional 780 shares in the last quarter. Finally, Commerce Bank increased its position in shares of Wright Medical Group N.V. by 7.4% in the first quarter. Commerce Bank now owns 18,837 shares of the medical device company’s stock worth $586,000 after buying an additional 1,300 shares in the last quarter.

Shares of Wright Medical Group N.V. (NASDAQ:WMGI) opened at 28.59 on Friday. Wright Medical Group N.V. has a 1-year low of $20.50 and a 1-year high of $31.53. The stock’s 50 day moving average is $27.67 and its 200-day moving average is $28.17. The stock’s market cap is $2.98 billion.

Wright Medical Group N.V. (NASDAQ:WMGI) last posted its quarterly earnings data on Wednesday, August 2nd. The medical device company reported ($0.07) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.09) by $0.02. The business had revenue of $179.69 million during the quarter, compared to the consensus estimate of $178.17 million. Wright Medical Group N.V. had a negative net margin of 36.04% and a negative return on equity of 6.22%. The business’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.11) earnings per share. On average, analysts anticipate that Wright Medical Group N.V. will post ($0.29) EPS for the current year.

WARNING: This news story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international copyright and trademark law. The original version of this news story can be read at https://www.thecerbatgem.com/2017/08/26/384213-shares-in-wright-medical-group-n-v-wmgi-acquired-by-marshall-wace-north-america-l-p.html.

A number of equities analysts have recently issued reports on the stock. ValuEngine upgraded shares of Wright Medical Group N.V. from a “sell” rating to a “hold” rating in a report on Friday, June 2nd. BidaskClub upgraded shares of Wright Medical Group N.V. from a “sell” rating to a “hold” rating in a report on Friday, August 11th. Piper Jaffray Companies reiterated a “buy” rating and set a $34.00 price target on shares of Wright Medical Group N.V. in a report on Thursday, August 3rd. Jefferies Group LLC reiterated a “buy” rating and set a $33.00 price target on shares of Wright Medical Group N.V. in a report on Friday, August 4th. Finally, BMO Capital Markets reiterated a “buy” rating and set a $34.00 price target on shares of Wright Medical Group N.V. in a report on Thursday, May 4th. Six analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Wright Medical Group N.V. presently has an average rating of “Buy” and a consensus price target of $32.25.

In other news, SVP Jennifer S. Walker sold 20,000 shares of the business’s stock in a transaction dated Wednesday, July 19th. The shares were sold at an average price of $28.00, for a total transaction of $560,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Julie Andrews sold 1,480 shares of the business’s stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $27.11, for a total transaction of $40,122.80. The disclosure for this sale can be found here. Insiders have sold 40,655 shares of company stock valued at $1,116,708 over the last 90 days. 9.30% of the stock is currently owned by insiders.

About Wright Medical Group N.V.

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Want to see what other hedge funds are holding WMGI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Wright Medical Group N.V. (NASDAQ:WMGI).

Institutional Ownership by Quarter for Wright Medical Group N.V. (NASDAQ:WMGI)

Receive News & Stock Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related stocks with our FREE daily email newsletter.